HIT Standards Committee Advisory Meeting; Notice of Meeting, 46298-46299 [2011-19536]
Download as PDF
46298
Federal Register / Vol. 76, No. 148 / Tuesday, August 2, 2011 / Notices
person on or before two days prior to
the workgroup’s meeting date. Oral
comments from the public will be
scheduled at the conclusion of each
workgroup meeting. Time allotted for
each presentation will be limited to
three minutes. If the number of speakers
requesting to comment is greater than
can be reasonably accommodated
during the scheduled open public
session, ONC will take written
comments after the meeting until close
of business on that day.
If you require special
accommodations due to a disability,
please contact Judy Sparrow at least
seven (7) days in advance of the
meeting.
ONC is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://healthit.hhs.gov for procedures
on public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act
(Pub. L. 92–463, 5 U.S.C., App. 2).
Dated: July 25, 2011.
Judith Sparrow,
Office of Programs and Coordination, Office
of the National Coordinator for Health
Information Technology.
[FR Doc. 2011–19551 Filed 8–1–11; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
HIT Policy Committee Advisory
Meeting; Notice of Meeting
Office of the National
Coordinator for Health Information
Technology, HHS.
ACTION: Notice of meeting.
AGENCY:
erowe on DSK5CLS3C1PROD with NOTICES
This notice announces a forthcoming
meeting of a public advisory committee
of the Office of the National Coordinator
for Health Information Technology
(ONC). The meeting will be open to the
public.
Name of Committee: HIT Policy
Committee.
General Function of the Committee: To
provide recommendations to the National
Coordinator on a policy framework for the
development and adoption of a nationwide
health information technology infrastructure
that permits the electronic exchange and use
of health information as is consistent with
the Federal Health IT Strategic Plan and that
includes recommendations on the areas in
which standards, implementation
specifications, and certification criteria are
needed.
Date and Time: The meeting will be held
on August 3, 2011, from 10 a.m. to 2 p.m.
Eastern Time.
VerDate Mar<15>2010
15:03 Aug 01, 2011
Jkt 223001
Location: Marriott Wardman Park Hotel,
2660 Woodley Road, NW., Washington, DC.
For up-to-date information, go to the ONC
Web site, https://healthit.hhs.gov.
Contact Person: Judy Sparrow, Office of the
National Coordinator, HHS, 330 C Street,
SW., Washington, DC 20201, 202–205–4528,
Fax: 202–690–6079, e-mail:
judy.sparrow@hhs.gov. Please call the contact
person for up-to-date information on this
meeting. A notice in the Federal Register
about last minute modifications that impact
a previously announced advisory committee
meeting cannot always be published quickly
enough to provide timely notice.
Agenda: The committee will hear reports
from its workgroups, including the
Meaningful Use Workgroup, the Privacy &
Security Tiger Team, the Information
Exchange Workgroup, and the Quality
Measures Workgroup. ONC intends to make
background material available to the public
no later than two (2) business days prior to
the meeting. If ONC is unable to post the
background material on its Web site prior to
the meeting, it will be made publicly
available at the location of the advisory
committee meeting, and the background
material will be posted on ONC’s Web site
after the meeting, at https://healthit.hhs.gov.
Procedure: Interested persons may present
data, information, or views, orally or in
writing, on issues pending before the
committee. Written submissions may be
made to the contact person on or before
August 1, 2011. Oral comments from the
public will be scheduled between
approximately 1 and 2 p.m. Time allotted for
each presentation is limited to three minutes.
If the number of speakers requesting to
comment is greater than can be reasonably
accommodated during the scheduled open
public hearing session, ONC will take written
comments after the meeting until close of
business.
Persons attending ONC’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
ONC welcomes the attendance of the
public at its advisory committee meetings.
Seating is limited at the location, and ONC
will make every effort to accommodate
persons with physical disabilities or special
needs. If you require special accommodations
due to a disability, please contact Judy
Sparrow at least seven (7) days in advance of
the meeting.
ONC is committed to the orderly conduct
of its advisory committee meetings. Please
visit our Web site at https://healthit.hhs.gov
for procedures on public conduct during
advisory committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act
(Pub. L. 92–463, 5 U.S.C., App. 2).
Dated: July 25, 2011.
Judith Sparrow,
Office of Programs and Coordination, Office
of the National Coordinator for Health
Information Technology.
[FR Doc. 2011–19555 Filed 8–1–11; 8:45 am]
BILLING CODE 4150–45–P
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
HIT Standards Committee Advisory
Meeting; Notice of Meeting
Office of the National
Coordinator for Health Information
Technology, HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces a forthcoming
meeting of a public advisory committee
of the Office of the National Coordinator
for Health Information Technology
(ONC). The meeting will be open to the
public.
Name of Committee: HIT Standards
Committee.
General Function of the Committee: to
provide recommendations to the
National Coordinator on standards,
implementation specifications, and
certification criteria for the electronic
exchange and use of health information
for purposes of adoption, consistent
with the implementation of the Federal
Health IT Strategic Plan, and in
accordance with policies developed by
the HIT Policy Committee.
Date and Time: The meeting will be
held virtually on August 17, 2011, from
9 a.m. to 3 p.m./Eastern Time.
Location: The meeting will be
conducted virtually only. Dial into the
meeting: 1–877–705–6006. For up-todate information, go to the ONC Web
site, https://healthit.hhs.gov.
Contact Person: Judy Sparrow, Office
of the National Coordinator, HHS, 330 C
Street, SW., Washington, DC 20201,
202–205–4528, Fax: 202–690–6079,
e-mail: judy.sparrow@hhs.gov. Please
call the contact person for up-to-date
information on this meeting. A notice in
the Federal Register about last minute
modifications that impact a previously
announced advisory committee meeting
cannot always be published quickly
enough to provide timely notice.
Agenda: The committee will hear
reports from its workgroups, including
the Clinical Operations, Vocabulary
Task Force, Clinical Quality,
Implementation, and Enrollment
Workgroups. ONC intends to make
background material available to the
public no later than two (2) business
days prior to the meeting. If ONC is
unable to post the background material
on its Web site prior to the meeting, it
will be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on ONC’s Web site after
the meeting, at https://healthit.hhs.gov.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
E:\FR\FM\02AUN1.SGM
02AUN1
Federal Register / Vol. 76, No. 148 / Tuesday, August 2, 2011 / Notices
before the committee. Written
submissions may be made to the contact
person on or before August 15, 2011.
Oral comments from the public will be
scheduled between approximately 2 and
3 p.m./Eastern Time. Time allotted for
each presentation will be limited to
three minutes each. If the number of
speakers requesting to comment is
greater than can be reasonably
accommodated during the scheduled
open public hearing session, ONC will
take written comments after the meeting
until close of business.
Persons attending ONC’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
ONC welcomes the attendance of the
public at its advisory committee
meetings. Seating is limited at the
location, and ONC will make every
effort to accommodate persons with
physical disabilities or special needs. If
you require special accommodations
due to a disability, please contact Judy
Sparrow at least seven (7) days in
advance of the meeting.
ONC is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://healthit.hhs.gov for procedures
on public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act
(Pub. L. 92–463, 5 U.S.C., App. 2).
Dated: July 25, 2011.
Judith Sparrow,
Office of Programs and Coordination, Office
of the National Coordinator for Health
Information Technology.
[FR Doc. 2011–19536 Filed 8–1–11; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–190]
NIOSH List of Antineoplastic and Other
Hazardous Drugs in Healthcare
Settings 2012: Proposed Additions and
Deletions to the NIOSH Hazardous
Drug List
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of Draft Document
Available for Public Comment.
erowe on DSK5CLS3C1PROD with NOTICES
AGENCY:
VerDate Mar<15>2010
15:03 Aug 01, 2011
Jkt 223001
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the availability of the
following draft document for public
comment entitled ‘‘NIOSH List of
Antineoplastic and Other Hazardous
Drugs in Healthcare Settings 2012:
Proposed Additions and Deletions to the
NIOSH Hazardous Drug List.’’ The
document and instructions for
submitting comments can be found at
https://www.cdc.gov/niosh/docket/
review/docket190/default.html.
This guidance document does not
have the force and effect of law.
Public Comment Period: Comments
must be received by October 3, 2011.
ADDRESSES: Written comments may be
submitted to the NIOSH Docket Office,
identified by Docket Number NIOSH–
190, by any of the following methods:
• Mail: NIOSH Docket Office, Robert
A. Taft Laboratories, MS–C34, 4676
Columbia Parkway, Cincinnati, Ohio
45226.
• Facsimile: (513) 533–8285.
• E-mail: nioshdocket@cdc.gov.
All information received in response
to this notice will be available for public
examination and copying at the NIOSH
Docket Office, 4676 Columbia Parkway,
Cincinnati, Ohio 45226.
A complete electronic docket
containing all comments submitted will
be available on the NIOSH web page at
https://www.cdc.gov/niosh/docket, and
comments will be available in writing
by request. NIOSH includes all
comments received without change in
the docket, including any personal
information provided. All electronic
comments should be formatted as
Microsoft Word. Please make reference
to Docket Number NIOSH–190.
SUPPLEMENTARY INFORMATION:
Background: The NIOSH Alert:
Preventing Occupational Exposures to
Antineoplastic and Other Hazardous
Drugs in Health Care Settings was
published in September 2004 (https://
www.cdc.gov/niosh/docs/2004–165/).
This Alert contained Appendix A which
was a list of drugs that were deemed to
be hazardous and may require special
handling. This list of hazardous drugs
was updated in 2010 and covered all
new approved drugs and drugs with
new warning since 2007 (https://
www.cdc.gov/niosh/docs/2010–167/).
Between June 2007 and December 2009,
48 new drugs received FDA approval
and 115 drugs received special warnings
(usually black box warnings) based on
reported adverse effects in patients. The
complete list of these drugs can be
found at: https://www.cdc.gov/niosh/
SUMMARY:
PO 00000
Frm 00033
Fmt 4703
Sfmt 9990
46299
docket/review/docket190/pdfs/
Proposedchanges07112011.pdf. From
this list of 169 drugs, 45 drugs were
identified by NIOSH as candidate
hazardous drugs. Seven of these drugs
had safe handling recommendations
from the manufacturer and NIOSH is
accepting these recommendations as
appropriate. Therefore, these seven
drugs will be listed as hazardous
without requiring further review. A
panel consisting of peer reviewers and
stakeholders was asked to review and
comment on the remaining 38
potentially hazardous drugs. In
addition, the panel members were asked
to comment on the removal of 15 drugs
from the 2010 Hazardous Drug List.
Reviewers were not asked to provide a
consensus opinion and NIOSH made the
final determination regarding additions
and deletions to the 2010 hazardous
drug List.
NIOSH reviewed the
recommendations of the peer reviewers
and stakeholders and determined that
24 drugs in addition to the 7 drugs with
manufacturer’s warnings, were
determined to have one or more
characteristics of a hazardous drug and
this list of 31 drugs is being published
for comment in NIOSH Docket Number
190. In addition, 15 drugs from the 2010
Hazardous Drug List are being
considered for removal. Four drugs were
evaluated for reclassification, two drugs
are radio-pharmaceuticals which are
covered by specific handling regulations
set by the Nuclear Regulatory
Commission and nine others are not
available in the United States at this
time. In order to keep the list as current
as possible, NIOSH will remove any
drugs that are no longer available in the
United States. If any of these drugs were
to become available at a later date,
NIOSH would reconsider them for
review.
FOR FURTHER INFORMATION CONTACT:
Barbara MacKenzie, NIOSH, Robert A.
Taft Laboratories, 4676 Columbia
Parkway, MS–C26, Cincinnati, Ohio
45226, telephone (513) 533–8132, Email hazardousdrugs@cdc.gov.
Reference: https://www.cdc.gov/niosh/
docket/review/docket190/pdfs/
PanelSummary05092011.pdf.
Dated: July 22, 2011.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2011–19460 Filed 8–1–11; 8:45 am]
BILLING CODE 4163–19–P
E:\FR\FM\02AUN1.SGM
02AUN1
Agencies
[Federal Register Volume 76, Number 148 (Tuesday, August 2, 2011)]
[Notices]
[Pages 46298-46299]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-19536]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
HIT Standards Committee Advisory Meeting; Notice of Meeting
AGENCY: Office of the National Coordinator for Health Information
Technology, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Office of the National Coordinator for Health
Information Technology (ONC). The meeting will be open to the public.
Name of Committee: HIT Standards Committee.
General Function of the Committee: to provide recommendations to
the National Coordinator on standards, implementation specifications,
and certification criteria for the electronic exchange and use of
health information for purposes of adoption, consistent with the
implementation of the Federal Health IT Strategic Plan, and in
accordance with policies developed by the HIT Policy Committee.
Date and Time: The meeting will be held virtually on August 17,
2011, from 9 a.m. to 3 p.m./Eastern Time.
Location: The meeting will be conducted virtually only. Dial into
the meeting: 1-877-705-6006. For up-to-date information, go to the ONC
Web site, https://healthit.hhs.gov.
Contact Person: Judy Sparrow, Office of the National Coordinator,
HHS, 330 C Street, SW., Washington, DC 20201, 202-205-4528, Fax: 202-
690-6079, e-mail: judy.sparrow@hhs.gov. Please call the contact person
for up-to-date information on this meeting. A notice in the Federal
Register about last minute modifications that impact a previously
announced advisory committee meeting cannot always be published quickly
enough to provide timely notice.
Agenda: The committee will hear reports from its workgroups,
including the Clinical Operations, Vocabulary Task Force, Clinical
Quality, Implementation, and Enrollment Workgroups. ONC intends to make
background material available to the public no later than two (2)
business days prior to the meeting. If ONC is unable to post the
background material on its Web site prior to the meeting, it will be
made publicly available at the location of the advisory committee
meeting, and the background material will be posted on ONC's Web site
after the meeting, at https://healthit.hhs.gov.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending
[[Page 46299]]
before the committee. Written submissions may be made to the contact
person on or before August 15, 2011. Oral comments from the public will
be scheduled between approximately 2 and 3 p.m./Eastern Time. Time
allotted for each presentation will be limited to three minutes each.
If the number of speakers requesting to comment is greater than can be
reasonably accommodated during the scheduled open public hearing
session, ONC will take written comments after the meeting until close
of business.
Persons attending ONC's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
ONC welcomes the attendance of the public at its advisory committee
meetings. Seating is limited at the location, and ONC will make every
effort to accommodate persons with physical disabilities or special
needs. If you require special accommodations due to a disability,
please contact Judy Sparrow at least seven (7) days in advance of the
meeting.
ONC is committed to the orderly conduct of its advisory committee
meetings. Please visit our Web site at https://healthit.hhs.gov for
procedures on public conduct during advisory committee meetings.
Notice of this meeting is given under the Federal Advisory
Committee Act (Pub. L. 92-463, 5 U.S.C., App. 2).
Dated: July 25, 2011.
Judith Sparrow,
Office of Programs and Coordination, Office of the National Coordinator
for Health Information Technology.
[FR Doc. 2011-19536 Filed 8-1-11; 8:45 am]
BILLING CODE 4150-45-P